Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: 2 - What They Never Told You

Pfizer Strikes Deal With French Vaccine Maker -- Buy Or Sell?

Pharmaceutical company Pfizer (PFE) reported impressive first-quarter financials and is well-positioned to benefit from the equity subscription agreement with French vaccine maker Valneva. However, given the growing economic uncertainty, would it be worth adding the stock to your portfolio? Read more to find out.

StockNews.com

Why Shares Of Valneva SE Are Soaring Today

Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15.

Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Valneva agrees vaccine settlement with UK Government

Westminster had ordered, then cancelled, an agreement with the business

Insider UK

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EU Says Final Decision Yet To Be Taken On Terminating Valneva COVID-19 Vaccine Deal

The European Commission said that no final decision had been made about the possible termination of a contract with Valneva SE (NASDAQ: VALN) to supply its COVID-19 vaccine to the European Union.

Benzinga

Why Valneva's Shares Are Plunging Today Premarket

Valneva SE (NASDAQ:VALN) warned it might have to reconsider its FY22 financial guidance after the European Commission informed the company of its intent to terminate an advance purchase agreement (APA) for its VLA2001 COVID-19 candidate vaccine. In November, the company signed the APA with the European Commission to supply up to 60 million doses of…

Benzinga

Masks no longer obligatory in French public transport as Covid epidemic weakens

As the number of Covid-related hospitalisations and infection rates continue to decline, the French authorities have dropped the obligation for passengers in public transport to wear masks. From Monday, users of metros, buses, trains, planes and taxis will no longer be told to cover up.

Radio France Internationale

How To Attend Valneva Q1 2022 Earnings Conference Call

Valneva (NASDAQ:VALN) will host a conference call at 09:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Valneva (VALN) Conference Call Follow this link to access the live webcast.

Benzinga

Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate

Valneva SE (NASDAQ:VALN) and Pfizer Inc (NYSE:PFE) have reported Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. In pediatric participants (5-17 years old) who received VLA15 in either the two-dose schedule (N=93) or three-dose schedule (N=97), VLA15 was found to be more immunogenic than in adults with both vaccination schedules tested. These…

Benzinga

The Valneva COVID vaccine has been approved for use in the UK – here's what the evidence says

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new COVID vaccine. VLA2001 is manufactured by French pharmaceutical company Valneva for use in the UK and was approved on April 14 for use in adults between the ages of 18 and 50 for first and second doses.

The Conversation

Covid vaccine developed in West Lothian is approved

It is the sixth Covid-19 vaccine to be granted an MHRA authorisation for use in Britain

Daily Record

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Record

Millions of covid vaccine doses set to be manufactured in Scotland after new jab approved

Plans to hire 200 workers at the Livingston plant were put into question last year after Boris Johnson pulled the plug on a £1billion contract to buy 100million doses of the vaccine.

The Independent UK

Valneva: Everything we know about the new covid vaccine

The UK’s medicines regulator is the first in the world to approve the jab

Evening Standard

Covid infections fall in England for the first time in six weeks

Covid-19 infections have fallen for the first time in England in six weeks but Wales remains at a record high, the latest figures show.

Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100's of premium titles.
One news app.

Bristol Post

New Valneva covid vaccine and its links to Bristol explained

The UK has become the first major country to approve Valneva's vaccine against covid-19

Benzinga

Valneva Shares Jump As Its COVID-19 Vaccine Receives Conditional Approved In UK

The Healthcare products Regulatory Agency (MHRA) of the U.K. has granted Conditional Marketing Authorization for Valneva SE's (NASDAQ:VALN)COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age. MHRA found that VLA2001 meets safety, quality, and effectiveness standards. This new marketing authorization comes in addition to the emergency use authorization,…

Chronicle Live

UK becomes first country in the world to approve new Valneva Covid vaccine

It is the sixth Covid jab to be given the go-ahead in the UK

The Independent UK

UK clears 6th COVID shot despite canceling deal for doses

British authorities have authorized a coronavirus vaccine for adults made by French drugmaker Valneva

Daily Record

New Covid vaccine Valneva approved for UK use 'may be more effective for longer'

The jab developed by the firm, which has a factory in Livingston near Edinburgh, is the sixth Covid-19 vaccine to be granted an MHRA authorisation.

Wales Online

New Valneva Covid vaccine will be used in Wales

First Minister Mark Drakeford says having another vaccine makes the system 'more resilient'

Manchester Evening News

New Valneva Covid-19 vaccine approved in the UK

The approval comes as rising cases have a "major impact" on the NHS

1 2 3

People

Boris Johnson

24,055 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.